Recombinant Protein rMBP-NAP Restricts Tumor Progression by Triggering Antitumor Immunity in Mouse Metastatic Lung Cancer

Canadian Journal of Physiology and Pharmacology - Canada
doi 10.1139/cjpp-2017-0186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Canadian Science Publishing

Related search

Triggering Tumor Immunity Through Angiogenesis Targeting

Clinical Cancer Research
Cancer ResearchOncology
2007English

Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression

Cancer Research
Cancer ResearchOncology
2019English

A Mouse Model for Tumor Progression of Lung Cancer in Ras and P53 Transgenic Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Transforming Growth Factor Beta Regulation of Tumor Progression in Metastatic Cancer

2004English

Influenza Virus-Like Particles Engineered by Protein Transfer With Tumor-Associated Antigens Induces Protective Antitumor Immunity

Biotechnology and Bioengineering
Applied MicrobiologyBiotechnologyBioengineering
2015English

Whole Recombinant Yeast Vaccine Induces Antitumor Immunity and Improves Survival in a Genetically Engineered Mouse Model of Melanoma

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Enhancement of Antitumor Activity of Cisplatin in Human Lung Cancer Cells by Tumor Suppressor FUS1

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

Tumor Vasculature-Targeted Recombinant Mutated Human TNF-α Enhanced the Antitumor Activity of Doxorubicin by Increasing Tumor Vessel Permeability in Mouse Xenograft Models

PLoS ONE
Multidisciplinary
2014English

Antitumor Effects of L-Blp25 Antigen-Specific Tumor Immunotherapy in a Novel Human MUC1 Transgenic Lung Cancer Mouse Model

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy